These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19268683)

  • 41. Rational design of immunotoxins: current progress and future prospects.
    Wawrzynczak EJ
    Anticancer Drug Des; 1992 Oct; 7(5):427-41. PubMed ID: 1388633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural and functional characterization of a recombinant sticholysin I (rSt I) from the sea anemone Stichodactyla helianthus.
    Pazos F; Valle A; Martínez D; Ramírez A; Calderón L; Pupo A; Tejuca M; Morera V; Campos J; Fando R; Dyszy F; Schreier S; Horjales E; Alvarez C; Lanio ME; Lissi E
    Toxicon; 2006 Dec; 48(8):1083-94. PubMed ID: 17067649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of several sea anemone and scorpion toxins on excitability and ionic currents in the giant axon of the cockroach.
    Pelhate M; Laufer J; Pichon Y; Zlotkin E
    J Physiol (Paris); 1984; 79(4):309-17. PubMed ID: 6152295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preparation and characterization of conjugates of monoclonal antibodies and staphylococcal enterotoxin A using a new hydrophilic cross-linker.
    Akerblom E; Dohlsten M; Brynö C; Mastej M; Steringer I; Hedlund G; Lando P; Kalland T
    Bioconjug Chem; 1993; 4(6):455-66. PubMed ID: 8305515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sticholysin II, a cytolysin from the sea anemone Stichodactyla helianthus, is a monomer-tetramer associating protein.
    de los Ríos V; Mancheño JM; Martínez del Pozo A; Alfonso C; Rivas G; Oñaderra M; Gavilanes JG
    FEBS Lett; 1999 Jul; 455(1-2):27-30. PubMed ID: 10428465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pore formation: an ancient yet complex form of attack.
    Iacovache I; van der Goot FG; Pernot L
    Biochim Biophys Acta; 2008; 1778(7-8):1611-23. PubMed ID: 18298943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pore-forming bacterial cytolysins.
    Bhakdi S; Valeva A; Walev I; Zitzer A; Palmer M
    Symp Ser Soc Appl Microbiol; 1998; 27():15S-25S. PubMed ID: 9750358
    [No Abstract]   [Full Text] [Related]  

  • 48. New cytolysins in sea anemones from the west coast of the United States.
    Bernheimer AW; Avigad LS
    Toxicon; 1981; 19(4):529-34. PubMed ID: 6120588
    [No Abstract]   [Full Text] [Related]  

  • 49. Polypeptide cytolytic toxins from sea anemones (Actiniaria).
    Macek P
    FEMS Microbiol Immunol; 1992 Sep; 5(1-3):121-9. PubMed ID: 1384592
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interfacial activity of an ion channel-generating protein cytolysin from the sea anemone Stichodactyla helianthus.
    Doyle JW; Kem WR; Vilallonga FA
    Toxicon; 1989; 27(4):465-71. PubMed ID: 2567077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunotoxins and neuropeptide-toxin conjugates experimental applications.
    Lappi DA; Wiley RG
    Mini Rev Med Chem; 2004 Jun; 4(5):585-95. PubMed ID: 15180512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biophysical and biochemical strategies to understand membrane binding and pore formation by sticholysins, pore-forming proteins from a sea anemone.
    Alvarez C; Ros U; Valle A; Pedrera L; Soto C; Hervis YP; Cabezas S; Valiente PA; Pazos F; Lanio ME
    Biophys Rev; 2017 Oct; 9(5):529-544. PubMed ID: 28853034
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The toxin component of targeted anti-tumor toxins determines their efficacy increase by saponins.
    Weng A; Thakur M; Beceren-Braun F; Bachran D; Bachran C; Riese SB; Jenett-Siems K; Gilabert-Oriol R; Melzig MF; Fuchs H
    Mol Oncol; 2012 Jun; 6(3):323-32. PubMed ID: 22309811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Membrane damage by pore-forming bacterial cytolysins.
    Bhakdi S; Tranum-Jensen J
    Microb Pathog; 1986 Feb; 1(1):5-14. PubMed ID: 2854594
    [No Abstract]   [Full Text] [Related]  

  • 55. Resistance and vulnerability of crustaceans to cytolytic sea anemone toxins.
    Giese C; Mebs D; Werding B
    Toxicon; 1996 Aug; 34(8):955-8. PubMed ID: 8875782
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeted toxins.
    Wiley RG; Lappi DA
    Curr Protoc Neurosci; 2001 May; Chapter 1():Unit1.7. PubMed ID: 18428453
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure and membrane actions of a marine worm protein cytolysin, Cerebratulus toxin A-III.
    Kem WR
    Toxicology; 1994 Feb; 87(1-3):189-203. PubMed ID: 8160185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeted cytolysins synergistically potentiate cytoplasmic delivery of gelonin immunotoxin.
    Pirie CM; Liu DV; Wittrup KD
    Mol Cancer Ther; 2013 Sep; 12(9):1774-82. PubMed ID: 23832121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of the damage to membranes caused by bacterial cytolysins.
    Sekiya K; Futaesaku Y
    J Electron Microsc (Tokyo); 1998; 47(6):543-52. PubMed ID: 9972544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel therapeutic strategies to selectively kill cancer cells.
    Panchal RG
    Biochem Pharmacol; 1998 Feb; 55(3):247-52. PubMed ID: 9484789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.